Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-14

FDA Approved: MORPHINE SULFATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Morphine Sulfate from Hospira, Inc. under NDA 202515. This represents regulatory approval of a change to the exi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)